Maillard reaction products in tissue proteins: New products and new perspectives

[1]  M. Smith,et al.  Chemistry and biochemistry of oxidative stress in neurodegenerative disease. , 2001, Current medicinal chemistry.

[2]  N. Hotta,et al.  Rapid formation of advanced glycation end products by intermediate metabolites of glycolytic pathway and polyol pathway. , 1996, Biochemical and biophysical research communications.

[3]  Golubev Ag.  The other side of metabolism , 1996 .

[4]  J. Baynes.  From life to death – the struggle between chemistryand biology during aging: the Maillard reaction as an amplifier of genomic damage , 2004, Biogerontology.

[5]  J. Baynes.  The Maillard Hypothesis on Aging: Time to Focus on DNA , 2002, Annals of the New York Academy of Sciences.

[6]  S. Horiuchi,et al.  Peroxynitrite induces formation of N( epsilon )-(carboxymethyl) lysine by the cleavage of Amadori product and generation of glucosone and glyoxal from glucose: novel pathways for protein modification by peroxynitrite. , 2002, Diabetes.

[7]  K. Biemel,et al.  Formation Pathways for Lysine-Arginine Cross-links Derived from Hexoses and Pentoses by Maillard Processes , 2001, The Journal of Biological Chemistry.

[8]  A. Cerami,et al.  Mechanism of Inhibition of Advanced Glycosylation by Aminoguanidine in Vitro , 1993 .

[9]  T. Lyons,et al.  The Advanced Glycation End Product, N-(Carboxymethyl)lysine, Is a Product of both Lipid Peroxidation and Glycoxidation Reactions (*) , 1996, The Journal of Biological Chemistry.

[10]  S P Wolff,et al.  Glucose autoxidation and protein modification. The potential role of 'autoxidative glycosylation' in diabetes. , 1987, The Biochemical journal.

[11]  B. Szwergold,et al.  Human fructosamine-3-kinase: purification, sequencing, substrate specificity, and evidence of activity in vivo. , 2001, Diabetes.

[12]  J. Baynes,et al.  Glycoxidation and lipoxidation in atherogenesis. , 2000, Free radical biology & medicine.

[13]  K Nakamura,et al.  Acid-stable fluorescent advanced glycation end products: vesperlysines A, B, and C are formed as crosslinked products in the Maillard reaction between lysine or proteins with glucose. , 1997, Biochemical and biophysical research communications.

[14]  A. Golubev.  [The other side of metabolism]. , 1996, Biokhimiia.

[15]  J. Crowley,et al.  The myeloperoxidase system of human phagocytes generates Nepsilon-(carboxymethyl)lysine on proteins: a mechanism for producing advanced glycation end products at sites of inflammation. , 1999, The Journal of clinical investigation.

[16]  J. Baynes.  Role of Oxidative Stress in Development of Complications in Diabetes , 1991, Diabetes.

[17]  E. Niki,et al.  Protein-bound acrolein: potential markers for oxidative stress. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[18]  T. Miyata,et al.  Localization of identified advanced glycation end‐product structures, Nε=(carboxymethyl)lysine and pentosidine, in age‐related inclusions in human brains , 1998, Pathology international.

[19]  J. Hodge.  Dehydrated Foods, Chemistry of Browning Reactions in Model Systems , 1953 .